✦ LIBER ✦

Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients

✍ Scribed by Frédéric Kaffy; Catherine Borderie; Carine Chagneau; Marie Pierre Ripault; Isabelle Larzillière; Christine Silvain; Michel Beauchant

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[192] THE HEMODYNAMIC IMPAIRMENT IN CIRR

✍ C.G. Fierbinteanu-Braticevici; L. Tribus; A. Petrisor; R. Usvat; A. Bengus 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Renal blood flow in cirrhotic patients a

✍ HK Nagi,A Rasmy,S Hadad,S Mokhtar,H Mowafy 📂 Article 📅 2002 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 1021 KB

THE MAGNITUDE OF CARDIOVASCULAR CHANGE I

✍ Junpaparp, Parichart; Purushottam, Bhaskar; Buppajarntham, Saranya; Pomerantz, S 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 501 KB

Promising long-term efficacy of palliati

✍ Brensing, KA; Textor, J; Perz, J; Schiedermaier, P; Raab, P; Strunk, H; Klehr, H 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 169 KB

The treatment of the type 1 hepatorenal

✍ P. Angeli; R. Volpin; G. Gerunda; R. Craighero; P. Con; L. Caregaro; C. Merkel; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Role of therlipressine and octreotide in

✍ A.R. Abulfutuh; M.A. Morsy; A.M. Solyman; S.M. El Hendawy; M.E. El Desouky; S.M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 313 KB